Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioject Medical Technologies, a developer of needle-free injection therapy systems, has extended its supply agreement with Ferring Pharmaceuticals, a biopharmaceutical company, for the sale of its needle-free drug vial adapters.
Subscribe to our email newsletter
The new agreement extends the most recent agreement for an additional three years with two consecutive one year renewal options.
The Bioject drug vial adapter is a needle-free FDA 510(k)-released product. This vial adapter allows withdrawal of medication, withdrawal and transfer of diluents and reconstitution without the use of a needle. The non-sharps plastic device is used with Ferring’s proprietary drug.
Ralph Makar, president and CEO of Bioject, said: “We look forward to continuing our positive relationship with Ferring Pharmaceuticals and are pleased that they have decided to extend utilization of our unique needle-free vial adapter technology for another three to five years.
“The vial adapter offers many improvements and advantages to accessing medication and reconstitution of medication without the use of a needle and we have shown this to be very successful in other applications.”